Kartik R. Roy

An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells

Mohammad B. Uddin, Kartik R. Roy, Salman B. Hosain et al. · Biochemical Pharmacology · 2018 · 108 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +8

Ceramide–Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations

Sachin Khiste, Zhijun Liu, Kartik R. Roy et al. · Molecular Cancer Therapeutics · 2019 · 31 citations · Full text

Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation

Kartik R. Roy, Mohammad B. Uddin, Sagor C. Roy et al. · FASEB BioAdvances · 2020 · 18 citations · Full text

Rubusoside-assisted solubilization of poorly soluble C6-Ceramide for a pilot pharmacokinetic study

Jianzhong Chen, Sachin Khiste, Xiaomei Fu et al. · Prostaglandins & Other Lipid Mediators · 2019 · 16 citations · Full text

Pharmaceutical Science, Medicine, Rubusoside-assisted Solubilization +8

p53 missense mutant G242A subverts natural killer cells in sheltering mouse breast cancer cells against immune rejection

Mohammad B. Uddin, Kartik R. Roy, Ronald A. Hill et al. · Experimental Cell Research · 2022 · 15 citations

Cancer Research, Immune Rejection, Cancer Immunosurveillance +9